According to Selecta Biosciences's latest financial reports the company has a price-to-book ratio of 2.24.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.24 | 21.6% |
2022-12-31 | 1.84 | -89.09% |
2021-12-31 | 16.9 | -192.85% |
2020-12-31 | -18.2 | -174.33% |
2019-12-31 | 24.5 | -321.77% |
2018-12-31 | -11.0 | -360.88% |
2017-12-31 | 4.23 | -25.5% |
2016-12-31 | 5.68 | |
2015-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | 27.81% | ๐บ๐ธ USA |